{"id":"NCT03274895","sponsor":"SIFI SpA","briefTitle":"Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis","officialTitle":"Randomized, Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% PHMB Ophthalmic Solution in Comparison With 0.02% PHMB + 0.1% Propamidine Combination Therapy in Subjects Affected by Acanthamoeba Keratitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-13","primaryCompletion":"2021-06-30","completion":"2022-03-30","firstPosted":"2017-09-07","resultsPosted":"2023-08-02","lastUpdate":"2023-08-22"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acanthamoeba Keratitis"],"interventions":[{"type":"DRUG","name":"PHMB 0.08%","otherNames":["Polihexanide 0.8 mg/ml"]},{"type":"DRUG","name":"Propamidine 0.1%","otherNames":["Brolene eye drops"]},{"type":"DRUG","name":"placebo","otherNames":["Brolene vehicle"]},{"type":"DRUG","name":"PHMB 0.02%","otherNames":["Polihexanide 0.2 mg/ml"]}],"arms":[{"label":"PHMB 0.08% plus placebo","type":"EXPERIMENTAL"},{"label":"PHMB 0.02% plus propamidine 0.1%","type":"ACTIVE_COMPARATOR"}],"summary":"Prospective randomized study to evaluate the efficacy, safety and tolerability of 0.08% polihexanide (PHMB) eye drops in patients affected by acanthamoeba keratitis.\n\n130 subjects were assigned to one of the following 2 treatment groups: Group 1: 0.08% polihexanide (PHMB) + placebo Group 2: 0.02% polihexanide (PHMB) + 0.1% propamidine","primaryOutcome":{"measure":"Clinical Resolution Rate","timeFrame":"12 months","effectByArm":[{"arm":"PHMB 0.08% Plus Placebo","deltaMin":84.8,"sd":null},{"arm":"PHMB 0.02% Plus Propamidine 0.1%","deltaMin":88.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["Italy","Poland","United Kingdom"]},"refs":{"pmids":["31401556","33239413","37802392"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":69},"commonTop":["eye pain","ocular hyperemia","lacrimation increased","conjunctival hyperemia","eye irritation"]}}